ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Arcturus Therapeutics Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.42+0.08 (+0.77%)
Close on Oct 19, 2026
- Market cap
- $296.17M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Arcturus Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 23, 2026 | Sep 23, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2026 | Aug 25, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 1, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 22, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 19, 2024 | Jun 24, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 14, 2024 | Jun 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 14, 2024 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 5, 2024 | Apr 5, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2024 | Mar 19, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 14, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 7, 2024 | Mar 7, 2024 | SEC EDGAR |